# Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

> **NCT07346924** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Multiple Sclerosis (MS) Relapsing Remitting

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic dietary supplement
- **OTHER:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07346924
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346924, "Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07346924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*